COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,021 Articles (22,627 medRxiv, 8,394 bioRxiv)

Most recent first Previous |  Page 2260: Articles 22591-22600  | Next

Utility of Olfactory test as screening tool for COVID-19: A pilot study
Khare, P., Chander, A. M., Agrawal, K., Jayant, S. S., Mukherjee, S., Yadav, K., Gupta, R., Chaudhary, S., Srivastava, S., Muralidharan, S., Mohan, R., Chaudhary, S., Pal, R., Bansal, S., Kondepudi, K. K., Puri, G. D., BISHNOI, M., Bhadada, S. K.
10.1101/2020.09.03.20187294 — Posted: 2020-09-05
High prevalence of deep venous thrombosis in non-severe COVID-19 patients hospitalized for a neurovascular disease
Rouyer, O., Pierre-Paul, I.-N., Balde, A., Jupitet, D., Bindila, D., Geny, B., Wolff, V.
10.1101/2020.09.03.20187344 — Posted: 2020-09-05
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - a cross-sectional study
Khan, S. M. S., Qurieshi, M. A., Haq, I., Majid, S., Bhat, A. A., Nabi, S., Ganai, N. A., Zahoor, N., Nisar, A., Chowdri, I. N., Qazi, T. B., Kousar, R., Lone, A. A., Sabah, I., Nabi, S., Sumji, I. A., Kawoosa, M. F., Ayoub, S.
10.1101/2020.09.04.282640 — Posted: 2020-09-04
Clustering analysis of single nucleotide polymorphism data reveals population structure of SARS-CoV-2 worldwide
Li, Y., Liu, Q., Luo, Y.
10.1101/2020.09.04.283358 — Posted: 2020-09-04
Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
Bouwman, K. M., Tomris, I., Turner, H. L., van der Woude, R., Bosman, G. P., Herfst, S., Rockx, B., Haagmans, B., Ward, A., Boons, G.-J., de Vries, R. P.
10.1101/2020.09.04.282558 — Posted: 2020-09-04
A SARS-CoV-2 - host proximity interactome
Samavarchi-Tehrani, P., Abdouni, H., Knight, J. D. R., Astori, A., Samson, R., Lin, Z.-Y., Kim, D.-K., Knapp, J. J., St-Germain, J., Go, C. D., Larsen, B., Wong, C. J., Cassonnet, P., Demeret, C., Jacob, Y., Roth, F. P., Raught, B., Gingras, A.-C.
10.1101/2020.09.03.282103 — Posted: 2020-09-04 Discussion: Onsite | Offsite
Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.
Qiang, X., Zhu, S., Li, J., Wang, P., Tracey, K. J., Wang, H.
10.1101/2020.09.04.280081 — Posted: 2020-09-04
Preliminary report of preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates, SK-01 version 1 and OZG-3861 version 1
SIR KARAKUS, G., Tastan, C., Dilek Kancagi, D., Yurtsever, B., Tumentemur, G., Demir, S., Turan, R. D., Abanuz, S., Cakirsoy, D., Seyis, U., Ozer, S., Elibol, O., Elek, M., Ertop, G., Arbak, S., Acikel Elmas, M., Hemsinlioglu, C., Kocagoz, A. S., Hatirnaz Ng, O., Akyoney, S., Sahin, I., Ozbek, U., Telci, D., Sahin, F., Yalcin, K., Ovali, E.
10.1101/2020.09.04.277426 — Posted: 2020-09-04
SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of immune cells
Singh, Y., Trautwein, C., Fendel, R., Krickeberg, N., Held, J., Kreidenweiss, A., Berezhnoy, G., Bissinger, R., Ossowski, S., Salker, M. S., Casadei, N., Riess, O., The DeCOI
10.1101/2020.09.04.282780 — Posted: 2020-09-04 Discussion: Onsite
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore
Tyson, J. R., James, P., Stoddart, D., Sparks, N., Wickenhagen, A., Hall, G., Choi, J. H., Lapointe, H., Kamelian, K., Smith, A. D., Prystajecky, N., Goodfellow, I., Wilson, S. J., Harrigan, R., Snutch, T. P., Loman, N. J., Quick, J.
10.1101/2020.09.04.283077 — Posted: 2020-09-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).